Exelon 1

Exelon 1 is a medicine authorised by Swissmedic under authorisation number 54275. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 31 July 1997 and the authorisation is valid without a time limit. ATC code N06DA03 places the medicine in the group Psychoanaleptics.

  • Dispensing category B
  • Authorisation number 54275
  • ATC N06DA03
  • Synthetic medicines
Authorisation data
Authorisation number54275
NameExelon 1
Full nameExelon 1,5 mg, Kapseln
Authorisation holderNovartis Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN06DA03
First authorisation31 July 1997
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
3Exelon 1,5 mg, KapselnB31 July 1997
4Exelon 3 mg, KapselnB31 July 1997
5Exelon 4,5 mg, KapselnB31 July 1997
6Exelon 6 mg, KapselnB31 July 1997

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
8028Kapsel(n)N06DA0301.99.0.B
9956Kapsel(n)N06DA0301.99.0.B
102112Kapsel(n)N06DA0301.99.0.B
11028Kapsel(n)N06DA0301.99.0.B
12956Kapsel(n)N06DA0301.99.0.B
137112Kapsel(n)N06DA0301.99.0.B
14528Kapsel(n)N06DA0301.99.0.B
161112Kapsel(n)N06DA0301.99.0.B
18128Kapsel(n)N06DA0301.99.0.B
218112Kapsel(n)N06DA0301.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Exelon 1 authorised in Switzerland?

Yes. Exelon 1 is authorised by Swissmedic under authorisation number 54275, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Exelon 1 have?

Exelon 1 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Exelon 1?

The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com